Old Mission Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,977
| Closed | -$185K | – | 1195 |
|
|
2024
Q4 | $185K | Buy |
13,977
+1,687
| +14% | +$22.3K | ﹤0.01% | 837 |
|
|
2024
Q3 | $175K | Sell |
12,290
-210,768
| -94% | -$3M | ﹤0.01% | 805 |
|
|
2024
Q2 | $2.89M | Buy |
223,058
+124,087
| +125% | +$1.61M | 0.05% | 160 |
|
|
2024
Q1 | $1.37M | Sell |
98,971
-942,555
| -90% | -$13.1M | 0.02% | 311 |
|
|
2023
Q4 | $14.9M | Buy |
1,041,526
+973,935
| +1,441% | +$13.9M | 0.27% | 39 |
|
|
2023
Q3 | $1.05M | Sell |
67,591
-535,934
| -89% | -$8.29M | 0.02% | 383 |
|
|
2023
Q2 | $9.48M | Buy |
603,525
+575,892
| +2,084% | +$9.05M | 0.2% | 50 |
|
|
2023
Q1 | $455K | Buy |
+27,633
| New | +$455K | 0.01% | 613 |
|
|
2022
Q4 | – | Sell |
-57,838
| Closed | -$750K | – | 1195 |
|
|
2022
Q3 | $750K | Sell |
57,838
-177,616
| -75% | -$2.3M | 0.02% | 476 |
|
|
2022
Q2 | $3.31M | Buy |
+235,454
| New | +$3.31M | 0.09% | 170 |
|
|
2021
Q2 | – | Sell |
-81,274
| Closed | -$1.48M | – | 1175 |
|
|
2021
Q1 | $1.48M | Buy |
+81,274
| New | +$1.48M | 0.08% | 263 |
|
|
2020
Q4 | – | Sell |
-169,748
| Closed | -$3.03M | – | 658 |
|
|
2020
Q3 | $3.03M | Buy |
169,748
+79,631
| +88% | +$1.42M | 0.24% | 103 |
|
|
2020
Q2 | $1.62M | Buy |
90,117
+7
| +0% | +$126 | 0.12% | 137 |
|
|
2020
Q1 | $1.37M | Sell |
90,110
-19,993
| -18% | -$304K | 0.12% | 121 |
|
|
2019
Q4 | $2.17M | Sell |
110,103
-32,656
| -23% | -$644K | 0.17% | 95 |
|
|
2019
Q3 | $2.46M | Buy |
142,759
+3,490
| +3% | +$60K | 0.31% | 58 |
|
|
2019
Q2 | $2.47M | Sell |
139,269
-156,464
| -53% | -$2.77M | 0.31% | 66 |
|
|
2019
Q1 | $6.02M | Buy |
+295,733
| New | +$6.02M | 1.01% | 25 |
|